Greer, G, Tolbert, R.
Subjective reports of the effects of MDMA in a clinical setting. J Psychoactive Drugs
1986; 18: 319–27.
Mithoefer, MC, Wagner, MT, Mithoefer, AT, Jerome, L, Doblin, R.
The safety and efficacy of 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol
2010; 25: 439–52.
Mithoefer, MC, Wagner, MT, Mithoefer, AT, Jerome, L, Martin, SF, Yazar-Klosinski, B, et al.
Durability of improvement in PTSD symptoms and absence of harmful effects or drug dependency after MDM-assisted psychotherapy: a prospective long-term follow-up study. J Psychopharmacol
2013; 27: 28–39.
MDMA assisted psychotherapy found to have a large effect for chronic post-traumatic stress disorder. J Psychopharmacol
2013; 27: 865–6.
Could MDMA be useful in the treatment of PTSD? Prog Neurol Psychiatry
2012; 15: 4–7.
Bedi, G, Cecchi, GA, Slezak, DF, Carrillo, F, Sigman, M, de Wit, H.
A window into the intoxicated mind? Speech as an index of psychoactive drug effects. Neuropsychopharmacology
2014; 39: 2340–8.
Frye, CG, Wardle, MC, Norman, GJ, de Wit, H.
MDMA decreases the effects of simulated social rejection. Pharmacol Biochem Behav
2014; 117: 1–6.
Hysek, CM, Schmid, Y, Simmler, LD, Domes, G, Heinrichs, M, Eisenegger, C, et al.
MDMA enhances emotional empathy and prosocial behavior.
Soc Cogn Affect Neurosci
2013; Oct 23 (Epub ahead of print).
Wardle, MC, de Wit, H.
MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology (Berl)
2014; 231: 4219–29.
Kirkpatrick, MG, Lee, R, Wardle, MC, Jacob, S, de Wit, H.
Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacology
2014; 39: 1654–63.
Kirkpatrick, MG, Baggott, MJ, Mendelson, JE, Galloway, GP, Liechti, ME, Hysek, CM, et al.
MDMA effects consistent across laboratories. Psychopharmacology (Berl)
2014; 231: 3899–905.
Carhart-Harris, RL, Erritzoe, D, Williams, LTJ, Erritzoe, D, Wall, MB, Ferguson, B, et al.
The effects of acutely administered 3,4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level-dependent resting state functional connectivity. Biol Psychiatry
2014; 10 Jan (Epub ahead of print).
Doblin, R, Greer, G, Holland, J, Jerome, L, Mithoefer, MC, Sessa, B.
A reconsideration and response to Parrott AC (2013) “Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research”. Hum Psychopharmacol
2014; 29: 105–8.
Selvaraj, S, Hoshi, R, Bhagwagar, Z, Murthy, NV, Hinz, R, Cowen, P, et al.
Brain serotonin transporter binding in former users of MDMA (‘ecstasy’). Br J Psychiatry
2009; 194: 355–9.
Multidisciplinary Association for Psychedelic Studies (MAPS). Protocol MAA-1: A Placebo-Controlled, Randomized, Blinded, Dose Finding Phase 2 Pilot Safety Study of MDMA Assisted Therapy for Social Anxiety in Autistic Adults. Multidisciplinary Association for Psychedelic Studies (MAPS), 2013 (http://www.maps.org/research/mdma/MAA1_FINAL_Protocol_22Feb13_redact.pdf).